Advertisement

Topics

Pepperl+Fuchs GmbH Company Profile

07:13 EDT 19th September 2018 | BioPortfolio

Pepperl+Fuchs designs, produces and distributes electronic sensors and components for the global Automation market. Continuous innovation, enduring quality, and steady growth guarantees continued success.
The Factory Automation Division is a leading manufacturer of a wide range of industrial inductive, photoelectric and ultrasonic sensors. Complementing this line of mostly binary sensors, we also offer complex sensors, identification and communication systems.

The Process Automation Division is the market leader for intrinsically safe components and intrinsically safe decentralized peripherals. Our products easily connect with Fieldbus Components and allow the simple design of Fieldbus Topology.

Location

Königsberger Allee 87
Mannheim
68307
Germany

Contact

Phone: 49 (0)621 776-0
Fax: 49 (0)621 776-1000
Email: info@de.pepperl-fuchs.com


News Articles [184 Associated News Articles listed on BioPortfolio]

With Training, Startups Like Paige.AI Could Soon Diagnose Cancer

It turns out interpreting biopsies isn’t entirely unlike mapping the rocky terrain of Mars. Thomas Fuchs, a former research technologist at NASA, is taking some of what he learned in training algori...

Cambridge Research Biochemicals supports evaluation of new Fuchs Dystrophy treatment

Cambridge Research Biochemicals has announced that under the terms of a new contract with Leidos Biomedical Research, it will support the evaluation of a new treatment approach for Fuchs Dystrophy

Study highlights potential of ASO therapy to treat Fuchs endothelial corneal dystrophy patients

A proof-of-concept study carried out at UCL Institute of Ophthalmology with funding from Fight for Sight has highlighted the potential of a targeted antisense oligonucleotide therapy to treat Fuchs en...

Systec GmbH Introduces its new Business Partner Evidencia GmbH

Research, pharmaceuticals, life sciences and food: many laboratories rely on steam sterilizers or equipment where processes are monitored using pressure and temperature control. Thanks to our collabor...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Laufende Fusionskontrollverfahren: Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);

Datum der Anmeldung:28.08.2018Aktenzeichen:B3-128/18Unternehmen:Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);Produktmärkte:in.....

Laufende Fusionskontrollverfahren: The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB Innere Medizin GmbH & Co. KG, Monheim (D) und die UCB Primary Care GmbH, Monheim (D);

Datum der Anmeldung:07.08.2018Aktenzeichen:B3-119/18Unternehmen:The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB In....

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

Original-Research: CO.DON AG - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu CO.DON AG Unternehmen: CO.DON AG ISIN: DE000A1K0227 Anlass der Studie: Update Report Empfehlung: Buy se...

PubMed Articles [30 Associated PubMed Articles listed on BioPortfolio]

Fuchs' Uveitis in Iranian Patients: A Review of 89 Eyes.

To describe clinical and imaging features of Fuchs' Uveitis (FU) and investigate the rate of misdiagnosis in Iranian patients.

Association of the Gutta-Induced Microenvironment With Corneal Endothelial Cell Behavior and Demise in Fuchs Endothelial Corneal Dystrophy.

The number and size of guttae increase over time in Fuchs endothelial corneal dystrophy (FECD); however, the association between these physical parameters and disease pathogenesis is unclear.

Comparing Outcomes of Phacoemulsification with Femtosecond Laser-Assisted Cataract Surgery in Patients with Fuchs Endothelial Dystrophy.

To compare the outcome in patients with Fuchs Endothelial Dystrophy (FED) who underwent standard phacoemulsification versus Femtosecond Laser-Assisted Surgery (FLACS) in the treatment of visually sign...

Descemetorhexis Without Endothelial Keratoplasty Versus DMEK for Treatment of Fuchs Endothelial Corneal Dystrophy.

To compare the visual outcomes and associated morbidity of patients with Fuchs endothelial corneal dystrophy who were treated with either Descemet membrane endothelial keratoplasty (DMEK) or descemeto...

Quantitative Assessment of Aqueous Flare After Descemet Membrane Endothelial Keratoplasty for Fuchs Endothelial Dystrophy.

To assess aqueous flare as a measure of subclinical inflammation after Descemet membrane endothelial keratoplasty (DMEK) for Fuchs endothelial dystrophy.

Clinical Trials [57 Associated Clinical Trials listed on BioPortfolio]

Fuchs' Torsional Phaco Study

The primary objective is to compare the effect of torsional phacoemulsification and longitudinal phacoemulsification on central and peripheral corneal thickness/volume after cataract surge...

DMEK Versus DSAEK Study

The purpose of this study is to determine whether corneal transplantation by Descemet Membrane Endothelial Keratoplasty more favourable and cost-effective is compared to Descemet Stripping...

A Study Investigating the Safety, Tolerability, and Efficacy of MTP-131 Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)

This is a Phase 1/2, prospective, randomized, double-masked, vehicle controlled, paired-eye study in approximately 16 subjects to evaluate safety, tolerability and efficacy of MTP-131 opht...

Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy

The cornea forms our "window to the world". Hence, its transparency is of utmost importance for vision. Corneal endothelium plays a central role in the maintenance of a transparent corneal...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Companies [533 Associated Companies listed on BioPortfolio]

Pepperl+Fuchs GmbH

Pepperl+Fuchs designs, produces and distributes electronic sensors and components for the global Automation market. Continuous innovation, enduring quality, and steady growth guarantees continued succ...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "Pepperl+Fuchs GmbH" on BioPortfolio

We have published hundreds of Pepperl+Fuchs GmbH news stories on BioPortfolio along with dozens of Pepperl+Fuchs GmbH Clinical Trials and PubMed Articles about Pepperl+Fuchs GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pepperl+Fuchs GmbH Companies in our database. You can also find out about relevant Pepperl+Fuchs GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record